Business Context and Reporting Period
This Form 6-K filing by Origin Agritech Limited covers the month of July 2017. The report details the entry into material financing agreements on July 5, 2017, with L2 Capital LLC. The capital is intended to support global business expansion, specifically for biotechnology traits and elite corn germplasm deregulation and licensing, addressing strict capital control restrictions in China.
Key Financial Metrics and Capital Structure
The filing discloses specific terms for new debt and equity facilities rather than historical financial performance metrics such as revenue or profit.
- Loan Note Facility: Aggregate principal amount of $2,344,828 available in five tranches.
- Interest Rate: 8% per annum.
- Equity Line Facility: Up to $4,500,000 worth of ordinary shares available via put requests.
- Share Issuance: Up to 293,087 shares issued in connection with loan drawdowns; 108,696 shares issued immediately for the equity line commitment.
- Collateral: The Company has pledged its United States assets as security for the loan.
Material Changes and Terms
The primary material change is the establishment of the new financing structure with L2 Capital LLC. Key terms include:
- Tranche Structure: The first tranche of $1,402,298 is issued at closing. Subsequent tranches depend on the filing and effectiveness of registration statements.
- Prepayment Terms: The note is pre-payable at a premium ranging from 115% to 130% depending on the repayment date. Mandatory prepayment is triggered if the Company raises $2 million or more in other financing.
- Maturity: Each tranche matures six months from the date funds are received, extendable by prepaying one-twelfth of the outstanding principal.
- Default Conversion: Upon default, L2 may convert principal, interest, and premiums into shares at a 40% premium, with the conversion rate based on 100% of the lowest trading price during the 15 days prior to the event.
- Equity Pricing: Shares under the equity line are priced at 94% of the lowest VWAP during the five trading days following a put request.
Guidance, Risks, and Covenants
Management commentary indicates that these financing approaches are necessary to maintain project timelines despite Chinese capital controls. The filing highlights several risks and restrictive covenants:
- Financing Restrictions: The Company is restricted from entering further variable rate or convertible financing arrangements without L2's consent until the note is paid or converted.
- Merger/Acquisition Impact: While M&A is permitted, such arrangements may require full prepayment of the note. The equity credit facility cannot be transferred if the Company is not the surviving entity in a merger.
- Shareholder Approval: As a foreign private issuer, the Company is exempt from certain NASDAQ governance rules, and shareholder approval for these securities was not required, though NASDAQ was notified.
- Registration Obligations: The Company must file a resale prospectus within 40 days and indemnify L2 for securities law claims.
Investor Verification Checklist
- Verify the status of the registration statement for the equity line, as subsequent loan tranches depend on its filing and effectiveness.
- Monitor the Company's ability to meet the mandatory prepayment trigger if it raises $2 million or more in other financing.
- Assess the dilution impact of the 293,087 shares issued for the loan and the potential issuance of up to $4.5 million in shares via the equity line.
- Review the valuation of pledged United States assets to understand the security backing the $2.34 million loan.
- Confirm compliance with the 40-day deadline for filing the resale prospectus.